Users Coming Off Anti-Obesity Medications Put On Pounds Four Times Faster Than People Using Diet and Exercise

Fresh analysis indicates that people who discontinue popular slimming jabs like Mounjaro or Wegovy can put back on shed pounds much more quickly than those who halt traditional diet and exercise regimens.

Published data in a leading health publication demonstrates that while overweight people frequently drop about a fifth of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month after stopping.

"People purchasing such drugs should be cognizant of the potential of quick rebound weight gain when the medication is stopped," cautioned expert Dr. Susan Jebb.

Such speed of regain implies a return to original mass within about one and a half years.

Analyzing Therapies

The research, which looked at dozens of studies involving thousands of participants, compared the results of GLP-1 agonists with older methods.

Scientists emphasize that people who lose weight through diet and exercise generally see a slower creep back—around 100 grams monthly—post-intervention.

Understanding the Rapid Rebound

Nutrition scientists suggest the mode of action of the injections is key to understanding the heightened regain.

GLP-1 drugs mimic a natural hormone called GLP-1, which helps regulate feelings of fullness.

"Long-term administration of GLP-1 concentrations far above than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.

"Stopping of this medication means appetite is unsuppressed, making binge eating far more likely."

An Ongoing Condition?

The NHS suggest the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.

Professionals contend that, given the high risk of relapse, the treatment should be considered long-term.

This perspective is echoed by drug manufacturers, who say that the findings "emphasize the long-term nature of excess weight," similar to managing conditions like diabetes.

User Accounts

People who have come off the medication describe a powerful resurgence of cravings.

"It was like a switch that goes on and I was suddenly ravenous," recalled one woman.

The struggle is compounded if patients have not developed sustainable dietary or behavioural changes during therapy.

Widespread Use

Survey data indicate that millions of people in the UK have tried these injections in the past year, with interest remaining high.

• Adoption is more common among women than males.
• The middle-aged demographic shows the greatest usage rates.
• A large proportion obtain the medications through private healthcare rather than the NHS.

In conclusion, experts emphasize that while these medications are potent agents for weight loss, they are not a permanent solution and long-term success relies on integrated lifestyle support.